Goldman Sachs’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.41M | Buy |
182,249
+122,775
| +206% | +$2.3M | ﹤0.01% | 3080 |
|
|
2025
Q1 | $1.07M | Sell |
59,474
-107,461
| -64% | -$1.93M | ﹤0.01% | 3766 |
|
|
2024
Q4 | $2.81M | Buy |
166,935
+120,822
| +262% | +$2.03M | ﹤0.01% | 3269 |
|
|
2024
Q3 | $746K | Buy |
+46,113
| New | +$746K | ﹤0.01% | 3917 |
|
|
2024
Q2 | – | Sell |
-40,948
| Closed | -$606K | – | 4884 |
|
|
2024
Q1 | $606K | Sell |
40,948
-10,226
| -20% | -$151K | ﹤0.01% | 3896 |
|
|
2023
Q4 | $742K | Sell |
51,174
-7,348
| -13% | -$107K | ﹤0.01% | 3764 |
|
|
2023
Q3 | $632K | Buy |
58,522
+7,158
| +14% | +$77.3K | ﹤0.01% | 3776 |
|
|
2023
Q2 | $663K | Buy |
51,364
+2,081
| +4% | +$26.8K | ﹤0.01% | 3830 |
|
|
2023
Q1 | $651K | Buy |
49,283
+8,695
| +21% | +$115K | ﹤0.01% | 3934 |
|
|
2022
Q4 | $609K | Sell |
40,588
-201,803
| -83% | -$3.03M | ﹤0.01% | 3989 |
|
|
2022
Q3 | $2.86M | Buy |
242,391
+48,599
| +25% | +$573K | ﹤0.01% | 3081 |
|
|
2022
Q2 | $2.19M | Buy |
193,792
+131,125
| +209% | +$1.48M | ﹤0.01% | 3369 |
|
|
2022
Q1 | $1.87M | Sell |
62,667
-115,665
| -65% | -$3.46M | ﹤0.01% | 3643 |
|
|
2021
Q4 | $4.73M | Sell |
178,332
-56,997
| -24% | -$1.51M | ﹤0.01% | 2845 |
|
|
2021
Q3 | $8.54M | Buy |
235,329
+36,987
| +19% | +$1.34M | ﹤0.01% | 2389 |
|
|
2021
Q2 | $8.61M | Buy |
198,342
+37,487
| +23% | +$1.63M | ﹤0.01% | 2366 |
|
|
2021
Q1 | $5.5M | Sell |
160,855
-129,587
| -45% | -$4.43M | ﹤0.01% | 2597 |
|
|
2020
Q4 | $10.2M | Buy |
290,442
+197,168
| +211% | +$6.9M | ﹤0.01% | 2044 |
|
|
2020
Q3 | $2.24M | Buy |
93,274
+60,599
| +185% | +$1.45M | ﹤0.01% | 2837 |
|
|
2020
Q2 | $598K | Sell |
32,675
-189,905
| -85% | -$3.48M | ﹤0.01% | 3503 |
|
|
2020
Q1 | $3.47M | Sell |
222,580
-88,828
| -29% | -$1.39M | ﹤0.01% | 2465 |
|
|
2019
Q4 | $6.66M | Buy |
311,408
+21,287
| +7% | +$456K | ﹤0.01% | 2261 |
|
|
2019
Q3 | $5.43M | Buy |
290,121
+75,176
| +35% | +$1.41M | ﹤0.01% | 2273 |
|
|
2019
Q2 | $5.61M | Sell |
214,945
-3,930
| -2% | -$103K | ﹤0.01% | 2242 |
|
|
2019
Q1 | $5.63M | Sell |
218,875
-193,412
| -47% | -$4.97M | ﹤0.01% | 2363 |
|
|
2018
Q4 | $9.48M | Buy |
412,287
+201,730
| +96% | +$4.64M | ﹤0.01% | 1955 |
|
|
2018
Q3 | $6.76M | Buy |
210,557
+12,234
| +6% | +$393K | ﹤0.01% | 2266 |
|
|
2018
Q2 | $5.61M | Buy |
198,323
+147,310
| +289% | +$4.17M | ﹤0.01% | 2347 |
|
|
2018
Q1 | $1.81M | Buy |
51,013
+4,109
| +9% | +$145K | ﹤0.01% | 2930 |
|
|
2017
Q4 | $1.82M | Buy |
46,904
+28,123
| +150% | +$1.09M | ﹤0.01% | 2881 |
|
|
2017
Q3 | $477K | Buy |
18,781
+319
| +2% | +$8.1K | ﹤0.01% | 3526 |
|
|
2017
Q2 | $504K | Sell |
18,462
-638
| -3% | -$17.4K | ﹤0.01% | 3532 |
|
|
2017
Q1 | $632K | Sell |
19,100
-42,481
| -69% | -$1.41M | ﹤0.01% | 3381 |
|
|
2016
Q4 | $1.47M | Sell |
61,581
-115,228
| -65% | -$2.74M | ﹤0.01% | 2892 |
|
|
2016
Q3 | $6.49M | Buy |
176,809
+165,785
| +1,504% | +$6.08M | ﹤0.01% | 2086 |
|
|
2016
Q2 | $246K | Buy |
11,024
+2,834
| +35% | +$63.2K | ﹤0.01% | 3737 |
|
|
2016
Q1 | $170K | Buy |
8,190
+2,254
| +38% | +$46.8K | ﹤0.01% | 3843 |
|
|
2015
Q4 | $180K | Buy |
5,936
+1,716
| +41% | +$52K | ﹤0.01% | 3779 |
|
|
2015
Q3 | $104K | Sell |
4,220
-3,980
| -49% | -$98.1K | ﹤0.01% | 4150 |
|
|
2015
Q2 | $263K | Sell |
8,200
-3,998
| -33% | -$128K | ﹤0.01% | 3818 |
|
|
2015
Q1 | $435K | Sell |
12,198
-11,240
| -48% | -$401K | ﹤0.01% | 3404 |
|
|
2014
Q4 | $532K | Buy |
23,438
+13,837
| +144% | +$314K | ﹤0.01% | 3332 |
|
|
2014
Q3 | $187K | Sell |
9,601
-6,924
| -42% | -$135K | ﹤0.01% | 3985 |
|
|
2014
Q2 | $600K | Sell |
16,525
-5,565
| -25% | -$202K | ﹤0.01% | 3245 |
|
|
2014
Q1 | $857K | Buy |
22,090
+3,597
| +19% | +$140K | ﹤0.01% | 3087 |
|
|
2013
Q4 | $527K | Sell |
18,493
-15,829
| -46% | -$451K | ﹤0.01% | 3394 |
|
|
2013
Q3 | $1.23M | Buy |
34,322
+24,989
| +268% | +$895K | ﹤0.01% | 2817 |
|
|
2013
Q2 | $312K | Buy |
+9,333
| New | +$312K | ﹤0.01% | 3426 |
|